Profund Advisors’s AngioDynamics ANGO Stock Holding History

Profund Advisors’s Portfolio ANGO Stock Details ANGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-10,060	Closed	-$170K	–	1470
2016 Q4	$170K	Buy	+10,060	New	+$168K	0.01%	1486

Other funds holding ANGO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

SAM

Sentinel Asset Management Montpelier, Vermont $868K AUM 45.44% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Profund Advisors's ANGO Position: Q1 2017 in Review

Profund Advisors sold out of AngioDynamics (ANGO) in Q1 2017, closing a stake of 10,060 shares — an estimated $170K sold.

Profund Advisors first reported a position in ANGO in Q4 2016 and held it in 1 quarter. The position peaked at $170K in Q4 2016. 163 funds tracked by Wall St. Rank hold ANGO as of Q1 2017.

Profund Advisors reported no remaining AngioDynamics position as of Q1 2017 after selling out during the quarter.
Profund Advisors sold 10,060 AngioDynamics shares in Q1 2017, an estimated $170K.
Profund Advisors first reported a position in AngioDynamics in Q4 2016 and held it in 1 quarter.
Profund Advisors's AngioDynamics position peaked at $170K in Q4 2016.
163 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2017.

Based on Profund Advisors's 13F filing for Q1 2017, filed 25 Apr 2017.